Cambridge-based cell programming company bit.bio has introduced two new media kits for its iPSC-derived ioGlutamatergic ...
A newly identified experimental compound, XL20, has demonstrated neuroprotective effects in mouse models and human motor ...
Scientists at MD Anderson Cancer Center have revealed how ATRX mutations restructure chromatin and activate oncogenic ...
One receptor can protect antibodies from degradation, extend their half-life and become a drug target itself. Explore the ...
A commonly prescribed epilepsy drug has shown striking potential as a vaccine booster in a controlled human trial, more than ...
A new multiplex immunofluorescence workflow using standard laboratory equipment and open-source software enables detailed ...
A biomechanical well plate inspired by the pressure-sensing lateral line of fish can wirelessly monitor the pulse of multiple ...
As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...
South Korean researchers have developed an automated, modular cell-free protein synthesis platform that slashes preparation ...
A peptide vaccine targeting PCSK9 has demonstrated sustained antibody responses and reductions in LDL cholesterol and atherosclerotic plaque formation in animal models, offering a potential long-term ...
Preclinical study demonstrates effectiveness of experimental mRNA vaccine against neuroblastoma, reducing tumour size by 70 ...
Researchers at the University of Michigan have assembled a database of more than 50,000 chemical experiments, offering AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results